hordeolum
Conditions
Interventions
Sponsors
Beijing Tongren Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. At least 18 years old; 2. Accompanied by secondary chronic inflammatory nodules, without abscess or chalazion, manifested as eyelid redness, swelling, heat and pain, eyelid margin granuloma or thickening with telangiectasia; 3. At least 1 recurrence; 4. Before participating in this study, the hyperemic and swollen nodules did not improve after 2 weeks or more of non-surgical treatment; 5. No meibomian cyst formation; 6. Unwilling to undergo surgery.
Exclusion criteria
Exclusion criteria: 1. Suffering from underlying diseases that can be caused by exposure to wavelengths between 560nm and 1200nm, including recurrent herpes simplex infection, systemic lupus erythematosus and porphyria, etc.; 2. Pregnant or lactating women; 3. There is a history of radiotherapy or chemotherapy within 1 year before the study or a history of planned radiotherapy or chemotherapy within 2 months after IPL treatment; 4. Acute stye (usually less than 2 weeks); 5. Eyelid tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| number of inflammatory nodules;educed proportion of the nodule size;degree of congestion; | — |
Countries
China
Contacts
Public ContactJie Ying
Beijing Tongren Hospital Affiliated to Capital Medical University
Outcome results
None listed